This inventor holds 3 USPTO granted patents. Top assignee: Immunomedics, Inc.. Active years: 1997-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-2000
Title: Innovations of Seregulam V Govindan
Introduction
Seregulam V Govindan is a notable inventor based in Summit, NJ (US). He has made significant contributions to the field of radioimmunodetection and radioimmunotherapy. With a total of three patents to his name, his work has advanced the understanding and application of radionuclide-based technologies in medical diagnostics and treatment.
Latest Patents
Govindan's latest patents include innovative methods for the thiolation of proteins for radionuclide-based radioimmunodetection. One of his patents describes a method of radiolabeling a protein with a radionuclide. This involves contacting the protein with a protected tertiary thiol-containing bifunctional chelating agent. The agent is capable of reacting with the protein at one end and complexing with a radionuclide at the other end. This process forms a protein-acetyl-t-thiol-containing conjugate. The conjugate is then deprotected and mixed with a reducing agent for the radionuclide. Subsequently, the radionuclide is added to form a mixture that reacts with pendant sulfhydryl groups present on the protein-t-thiol-containing conjugate. His patents also disclose methods of radioimmunotherapy and diagnostic kits suitable for administration to human patients.
Career Highlights
Govindan is currently associated with Immunomedics, Inc., where he continues to innovate in the field of medical technology. His work has been instrumental in developing new diagnostic and therapeutic methods that leverage the properties of radionuclides.
Collaborations
He has collaborated with notable colleagues such as Hans J Hansen and Gary L Griffiths, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Seregulam V Govindan's contributions to the field of radioimmunodetection and radioimmunotherapy highlight his role as a leading inventor in medical technology. His innovative patents and collaborations continue to pave the way for advancements in patient care and treatment methodologies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile